ScoreWhy is Humanwell Healthcare (Group) Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 3.29% and Operating profit at 0.89% over the last 5 years
2
Flat results in Mar 25
- NET PROFIT(HY) At CNY 161.13 MM has Grown at -81.09%
- ROCE(HY) Lowest at 7.77%
- DEBTORS TURNOVER RATIO(HY) Lowest at 2.24%
3
With ROE of 9.29%, it has a fair valuation with a 1.68 Price to Book Value
- Over the past year, while the stock has generated a return of -19.50%, its profits have fallen by -33.7%
- At the current price, the company has a high dividend yield of 2.5
4
Below par performance in long term as well as near term
- Along with generating -19.50% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Humanwell Healthcare (Group) Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Humanwell Healthcare (Group) Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Humanwell Healthcare (Group) Co., Ltd.
-19.5%
-0.05
29.19%
China Shanghai Composite
14.77%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.29%
EBIT Growth (5y)
0.89%
EBIT to Interest (avg)
6.19
Debt to EBITDA (avg)
2.08
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
0.90
Tax Ratio
25.83%
Dividend Payout Ratio
57.69%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.69%
ROE (avg)
14.85%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.68
EV to EBIT
14.54
EV to EBITDA
10.07
EV to Capital Employed
1.55
EV to Sales
1.44
PEG Ratio
NA
Dividend Yield
2.49%
ROCE (Latest)
10.63%
ROE (Latest)
9.29%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -9.36% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 3.92%
-12What is not working for the Company
NET PROFIT(HY)
At CNY 161.13 MM has Grown at -81.09%
ROCE(HY)
Lowest at 7.77%
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.24%
NET SALES(Q)
Lowest at CNY 6,083.6 MM
Here's what is working for Humanwell Healthcare (Group) Co., Ltd.
Inventory Turnover Ratio
Highest at 3.92%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -9.36% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Humanwell Healthcare (Group) Co., Ltd.
Net Profit
At CNY 161.13 MM has Grown at -81.09%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
Lowest at CNY 6,083.6 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Debtors Turnover Ratio
Lowest at 2.24%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
